X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PANACEA BIOTECH - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PANACEA BIOTECH J.B.CHEMICALS/
PANACEA BIOTECH
 
P/E (TTM) x 13.9 80.7 17.2% View Chart
P/BV x 2.2 1.8 122.4% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   PANACEA BIOTECH
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
PANACEA BIOTECH
Mar-14
J.B.CHEMICALS/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs318149 213.9%   
Low Rs20082 242.4%   
Sales per share (Unadj.) Rs148.084.1 175.9%  
Earnings per share (Unadj.) Rs19.1-18.3 -104.2%  
Cash flow per share (Unadj.) Rs23.9-6.7 -357.5%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.983.7 154.0%  
Shares outstanding (eoy) m84.8261.25 138.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.4 127.4%   
Avg P/E ratio x13.6-6.3 -214.9%  
P/CF ratio (eoy) x10.8-17.2 -62.7%  
Price / Book Value ratio x2.01.4 145.5%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9517,074 310.3%   
No. of employees `0002.72.8 99.4%   
Total wages/salary Rs m1,8411,449 127.0%   
Avg. sales/employee Rs Th4,590.91,874.1 245.0%   
Avg. wages/employee Rs Th673.4527.0 127.8%   
Avg. net profit/employee Rs Th592.1-407.7 -145.2%   
INCOME DATA
Net Sales Rs m12,5515,154 243.5%  
Other income Rs m542100 542.7%   
Total revenues Rs m13,0935,254 249.2%   
Gross profit Rs m2,055-766 -268.1%  
Depreciation Rs m412711 58.0%   
Interest Rs m961,503 6.4%   
Profit before tax Rs m2,088-2,881 -72.5%   
Minority Interest Rs m011 -3.7%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m46917 2,792.2%   
Profit after tax Rs m1,619-1,121 -144.4%  
Gross profit margin %16.4-14.9 -110.1%  
Effective tax rate %22.5-0.6 -3,851.6%   
Net profit margin %12.9-21.8 -59.3%  
BALANCE SHEET DATA
Current assets Rs m7,7783,810 204.1%   
Current liabilities Rs m4,3588,365 52.1%   
Net working cap to sales %27.2-88.4 -30.8%  
Current ratio x1.80.5 391.8%  
Inventory Days Days55156 35.1%  
Debtors Days Days8067 119.0%  
Net fixed assets Rs m5,71314,480 39.5%   
Share capital Rs m17061 276.7%   
"Free" reserves Rs m10,547903 1,167.8%   
Net worth Rs m10,9375,127 213.3%   
Long term debt Rs m05,832 0.0%   
Total assets Rs m15,57419,433 80.1%  
Interest coverage x22.8-0.9 -2,489.9%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.80.3 303.9%   
Return on assets %11.02.0 560.5%  
Return on equity %14.8-21.9 -67.7%  
Return on capital %20.03.6 549.0%  
Exports to sales %48.724.5 198.7%   
Imports to sales %7.110.2 69.5%   
Exports (fob) Rs m6,1151,264 483.9%   
Imports (cif) Rs m889525 169.3%   
Fx inflow Rs m6,1691,539 400.8%   
Fx outflow Rs m1,285942 136.4%   
Net fx Rs m4,884597 817.8%   
CASH FLOW
From Operations Rs m1,397599 233.1%  
From Investments Rs m-320-438 73.1%  
From Financial Activity Rs m-1,196-303 395.2%  
Net Cashflow Rs m-102-141 72.4%  

Share Holding

Indian Promoters % 55.4 74.5 74.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.6 565.0%  
FIIs % 3.9 1.3 300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 23.6 156.8%  
Shareholders   30,437 10,259 296.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   GLENMARK PHARMA  UNICHEM LAB  CIPLA  ELDER PHARMA  VENUS REMEDIES  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS